Archives     Advertise     Editorial Calendar     Subscribe     Contact Us    


New Study Looks at Cost Impact of OTC Birth Control


 
Alexandra Wollum, MPH

On May 9, 'the pill' celebrates 60 years of approval from the Food and Drug Administration. While no over-the-counter option is currently available, a growing chorus of women's health providers, researchers and advocates is calling for improved access to oral contraceptives.

In April, new findings on the impact of over-the-counter costs for birth control pills on both use and unintended pregnancy were released in Women's Health Issues, a peer-reviewed, bimonthly journal of the Jacobs Institute of Women's Health.

"Modeling the Impacts of Price of an Over-the-Counter Progestin-Only Pill on Use and Unintended Pregnancy among U.S. Women" primarily looked at data from a nationally representative 2015 survey of more than 2,500 American women ages 15-44 to assess interest in using an OTC progestin-only pill at different price points. The analysis also utilized the National Survey of Family Growth 2013-15, which was released from the National Center for Health Statistics in 2016, as well as 2017 population data from the U.S. Census.

According to the analytical study: "In a model assuming no out-of-pocket costs, more than 12.5 million adults and 1.75 million teens reported likely use of an OTC progestin-only pill if available. Among adults, this resulted in an estimated 8 percent decrease in unintended pregnancy in one year. Adult and teen women on average were willing to pay $15 and $10, respectively, resulting in 7.1 million adult and 1.3 million teen users and an estimated 5 percent decrease in unintended pregnancy among adults."

Lead author Alexandra Wollum, MPH, senior project manager with Ibis Reproductive Health, noted, "These results show that an over-the-counter, progestin-only birth control pill at a low or no out-of-pocket cost has the potential to decrease unintended pregnancy rates and expand access for people of all ages."

Improving affordable, equitable access to healthcare is a timely topic with experts at the International Monetary Fund projecting a nearly 6 percent contraction in the U.S. economy in 2020. In the wake of layoffs resulting from COVID-19 business closures, more than 26 million Americans filed for unemployment over a five-week period between March and April, wiping out nearly a decade's worth of job gains and decreasing access to employer-sponsored insurance coverage.

"The findings of this study are particularly important in the middle of the public health crisis we're facing now," said Wollum. "As people struggle with mounting job losses and economic insecurity as a result of the COVID-19 pandemic, they must be able to obtain an affordable birth control pill over the counter to control their reproductive health. This study highlights the need for low or no out-of-pocket cost progestin-only birth control pills that are available over the counter to better meet people's healthcare needs."

"This study shows that people are willing to pay something out-of-pocket for the convenience of getting progestin-only pills over the counter," added co-author Dan Grossman, MD, professor in the Department of Obstetrics, Gynecology and Reproductive Science at the University of California San Francisco and director of Advancing New Standards in Reproductive Health (ANSRH) at UCSF. "But in order to best meet people's needs and help them plan their fertility, over-the-counter pills should be fully covered by insurance without co-pays and available at a very low cost or no cost for those without insurance,"

An earlier study published in February 2015 in the journal Contraception demonstrated affordability as a key factor for using OTC oral contraceptives among low-income populations. However, that study - led by Diana G. Foster, PhD, of ANSRH and co-authored by Grossman - did not use data that specifically looked at progestin-only pills (POP) in comparison to combined oral contraceptives (COC), which use both estrogen and progestin to prevent unintended pregnancies. While there are a wider choice of prescription COC options compared to prescription POPs (also known as the minipill), both are effective forms of contraception if taken appropriately. The new study specifically looked at the POP option, which has garnered growing consensus among industry groups as the more likely version to gain FDA approval to become the first oral contraceptives available without prescription.

The American College of Obstetricians and Gynecologists (ACOG) has issued a committee opinion highlighting barriers to access as one of the key reasons women don't use contraceptives consistently. Furthermore, the committee also found cost to be part of the larger access issue. "Pharmacist-provided contraception may be a necessary intermediate step to increase access to contraception, but over-the-counter access to hormonal contraception should be the ultimate goal," the opinion states. In addition to OTC oral contraceptives, ACOG has also called for similar access to vaginal rings, the contraceptive patch and depot medroxyprogesterone acetate injections without age restrictions.

The Jacobs Institute of Women's Health was founded in 1990 and is part of the Milken Institute School of Public Health at George Washington University in Washington, D.C. Women's Health Issues focuses on research related to women's healthcare and related public health policy.

WEB:

OTC POP Study

Women's Health Issues

Jacobs Institute of Women's Health

 
Share:

Related Articles:


Recent Articles

New Study Looks at Cost Impact of OTC Birth Control

A new study explores the impact on unintended pregnancies, consistent use of progestin-only OTC birth control pills at various price points.

Read More

Behavioral Health in a Time of Social Isolation

Last month, the Nashville Health Care Council brought together experts for a virtual panel discussion on behavioral health in the midst of social distancing orders.

Read More

COVID-19 & Mental Health

As the virus takes its toll, providers are finding new ways to reach patients and preparing for the mental health fallout ahead.

Read More

Self-Care on the Front Lines of Coronavirus

Physicians, nurses, respiratory therapists and the full complement of support staff at hospitals and clinics are battling coronavirus on the front lines. When caring for others, it's all too easy to forget to take care of yourself.

Read More

Sharing Best Practices in Behavioral Health

Nashville-based online video service provides evidence-based training to public and providers.

Read More

May is Mental Health Month

May is Mental Health Month with excellent resources from national organizations for both patients and providers.

Read More

Business Insights

Read More

Celebrating 15 Years of Incredible Leaders

Following are the 15 classes of Women to Watch. Some of these trailblazers have happily retired after a career of service. Others have moved to other positions and taken up new challenges since they were first recognized.

Read More

New Study Looks at Cost Impact of OTC Birth Control

A new study explores the impact on unintended pregnancies, consistent use of progestin-only OTC birth control pills at various price points.

Read More

AHA Releases Scientific Statement on CAD with Type 2 Diabetes

A new AHA scientific statement explores more aggressive clinical options for the patient-centered management of individuals with both type 2 diabetes and coronary artery disease.

Read More

Email Print
 
 

 

 


Tags:
Alexandra Wollum, Birth Control, Dan Grossman, Jacobs Institute, Oral Contraceptives, Over The Counter Birth Control, POP, Progestin-Only Pill, The Pill, Women's Health, Women's Health Issues
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: